Advertisement

Oral Diseases pp 161-174 | Cite as

Allergic, Toxic, and Drug-Induced Eruptions of the Oral Mucosa

  • L. E. Millikan

Abstract

Traditionally, the allergic types of reactions in the mucous membranes have been classified by the Coombs and Gel system. This includes types I-IV and covers most of the major pathologic events (Figs. 10.1–10.11) [1]. In brief, we can look on these as a useful way to sort out reactions as they occur, and provide insight into future potential problems.

Keywords

Atopic Dermatitis Mucous Membrane Contact Dermatitis Oral Mucosa Toxic Epidermal Necrolysis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Millikan LE. Drug eruptions. In: Moschella and Hurley, 3rd Edn. Philadelphia: Saunders, 1990Google Scholar
  2. 2.
    Roujeau JC SR. Severe adverse cutaneous reactions to drugs. N Engl J Med 1995; 331:1272–1285CrossRefGoogle Scholar
  3. 3.
    Wolkenstein PRJ. Drug-induced severe skin reactions. Incidence, management and prevention. Drug Saf 1995; 13:56–68PubMedCrossRefGoogle Scholar
  4. 4.
    Stewart MG DNr, Franklin DJ, Friedman EM, Sulek M. Head and neck manifestations of erythema multiforme in children. Otolaryngol Head Neck Surg 1994; 111:236–242PubMedCrossRefGoogle Scholar
  5. 5.
    Wilkins JML, White CR Jr. Oculocutaneous manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum. Dermatol Clin 1992; 10:571–PubMedGoogle Scholar
  6. 6.
    Roujeau JC. The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: a clinical classification. J Invest Dermatol 1994; 102:28S-3OSCrossRefGoogle Scholar
  7. 7.
    Breathnach SM PW. Epidemiology of bullous drug eruptions. Clin Dermatol 1993; 11:441–447PubMedCrossRefGoogle Scholar
  8. 8.
    Huff JC Erythema multiforme and latent herpes simplex infection. Semin Dermatol 1992; 11:207–210PubMedGoogle Scholar
  9. 9.
    Cherry JD. Anemia and mucocutaneous lesions due to Mycoplasma pneumoniae infections. Clin Infect Dis 1993; 17[Suppl 1] $47–51CrossRefGoogle Scholar
  10. 10.
    Roujeau JC KJ, Naldi L, Rzany B, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995; 333:1600–1607PubMedCrossRefGoogle Scholar
  11. 11.
    Litt J Drug Eruption Reference Manual (DERM). Cleveland: Wal-Zac Enterprises, 1996Google Scholar
  12. 12.
    Martin Mateos MA PA, Pastor X, Munoz Lopez F. Uncommon serious complications in Stevens-Johnson syndrome: a clinical case. J Investig Allergol Clin Immunol 1992; 2:278–283PubMedGoogle Scholar
  13. 13.
    Schlienger RG HW, Bircher A, Leib SL, Luscher TF. Drug-induced Stevens-Johnson syndrome in a patient with AIDS [German]. Schweiz Rundsch Med Prax 1993; 82:888–892PubMedGoogle Scholar
  14. 14.
    Sharma VK DS. Clinical pattern of cutaneous drug eruption among children and adolescents in north India. Pediatr Dermatol, 1995; 12:178–183PubMedCrossRefGoogle Scholar
  15. 15.
    Patterson RGL, Greenberger PA, Lawrence ID et al. Stevens-Johnson syndrome (SJS): effectiveness of corticosteroids in management and recurrent SJS. Allergy Proceedings, 1992;13:89–95PubMedCrossRefGoogle Scholar
  16. 16.
    Herndon D. Toxic epidermal necrolysis: a systemic and dermatologic disorder best treated with standard treatment protocols in burn intensive care units without the prolonged use of corticosteroids [editorial; comment]. J Am Coll Surg 1995; 180:273–278Google Scholar
  17. 17.
    Friedman PS SI, Pirmohamed M, Park BK. Investigation of mechanisms in toxic epidermal necrolysis induced by carbamazepine. Arch Dermatol 1994; 130:598–604CrossRefGoogle Scholar
  18. 18.
    Sturchler DMM, Kerr L. How frequent are notified severe cutaneous adverse reactions to Fansidar? Drug Saf 1993; 8:160–168PubMedCrossRefGoogle Scholar
  19. 19.
    Bastuji-Garin SRB, Stern RS, Shear NH et al. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993; 129:92–96PubMedCrossRefGoogle Scholar
  20. 20.
    Paquet PNA, Arrese JE, Vanderkelen A, Pierard GE. Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis. Arch Dermatol 1994; 130:605–608PubMedCrossRefGoogle Scholar
  21. 21.
    Guibal FB-GS, Chosidow O, Saiag P et al. Characteristics of toxic epidermal necrolysis in patients undergoing long-term glucocorticoid therapy. Arch Dermatol 1995; 131:669–672PubMedCrossRefGoogle Scholar
  22. 22.
    Cribier BPY, Grosshans E. Staphylococcal scalded skin syndrome in adults. A clinical review illustrated with a new case. J Am Acad Dermatol 1994; 30:319–324PubMedCrossRefGoogle Scholar
  23. 23.
    Kaufman DW. Epidemiologic approaches to the study of toxic epidermal necrolysis. J Invest Dermatol 1994; 102:31S-33SPubMedCrossRefGoogle Scholar
  24. 24.
    Carstens JWP, Sogaard H, Thestrup-Pedersen K. Toxic epidermal necrolysis and erythema multiforme following therapy with terbinafine. Acta Derm Venereol 1994; 74:391–392PubMedGoogle Scholar
  25. 25.
    Camisa C, Rindler J. Diseases of the oral mucous membranes. Curr Probl Dermatol 1996; 7:41–96Google Scholar
  26. 26.
    Parks ET Lesions associated with drug reaction. Dermatol Clin 1996; 14:327–337PubMedCrossRefGoogle Scholar
  27. 27.
    Fisher AA. Contact stomatitis and cheilitis. In: Fisher AA (Ed). Contact Dermatitis. Philadelphia: Lea and Febiger, 1986; 773–800Google Scholar
  28. 28.
    Nater JP, De Groot AC. Unwanted effects of cosmetics and drugs used in dermatology, 3rd Ed. Amsterdam: Elsevier Science Publishers, 1993; 187–189Google Scholar
  29. 29.
    Kaaber S, Thulin H, Nielsen E. Skin sensitivity to denture base materials in the burning mouth syndrome. Contact Dermatitis, 1979; 5:90–96PubMedCrossRefGoogle Scholar
  30. 30.
    Ali A, Bates JF. The burning mouth sensation related to the wearing of acrylic dentures: an investigation. Brit Dent J 1986; 444–447Google Scholar
  31. 31.
    Fisher AA. Contact stomatitis. Dermatol Clinics 5:708–717Google Scholar
  32. 32.
    Angelini G, Vena GA, Grandolfo M, Foti C, Pipoli M, Curatoli G. Contact cheilitis J Appl Cosmetol 1987; 11:91–101Google Scholar
  33. 33.
    Kanzaki T, Kabasawa Y, Jinno T, Isayama K Contact stomatitis due to methyl methacrylate monomer. Contact Dermatitis 1989; 20:146PubMedCrossRefGoogle Scholar
  34. 34.
    von Mayenburg J, Frosch P, Fuchs T et al. Mercury and amalgam sensitivity. Possible clinical manifestations and sources of contact sensitization. Dermatosen 1996; 5:213–221Google Scholar
  35. 35.
    Sainio EL, Kanerva L. Contact allergens in toothpastes and a review of their hypersensitivity. Contact Dermatitis 1995; 33:100–105PubMedCrossRefGoogle Scholar
  36. 36.
    Hisa T, Hamada T, Hirachi Y et al. Senile lip licking. Dermatology 1995; 191:339–340PubMedCrossRefGoogle Scholar
  37. 37.
    Hayakawa R, Matsunaga K, Suzuki M et al. Lipstick dermatitis due to Cl8 aliphatic compounds. Contact Dermatitis 1987; 16:215–219PubMedCrossRefGoogle Scholar
  38. 38.
    Aguirre A, Izu R, Gardeazabal J et al. Allergic contact cheilitis from a lipstick containing oxybenzone. Contact Dermatitis 1992; 27:267–268PubMedCrossRefGoogle Scholar
  39. 39.
    Romaguera C, Vilaplana J. Contact dermatitis from gallates. Am J Contact Dermatitis 1993; 2:231–234Google Scholar
  40. 40.
    Bruze M. Allergic contact cheilitis related to university studies. Contact Dermatitis 1994; 30:313PubMedCrossRefGoogle Scholar
  41. 41.
    Hausen BM. Häufigkeit und Bedeutung toxischer und allergischer Kontaktdermatitiden durch Machaerium scleroxylum Tul. (Pao Ferro), einem Ersatzholz für Palisander (Dalbergia nigra All.) Der Hautarzt 1982; 33:321–328Google Scholar
  42. 42.
    McFadden JP, Ingram MJ, Rycroft RJG. Contact allergy to cane reed in a clarinettist. Contact Dermatitis 1992; 27:117PubMedCrossRefGoogle Scholar
  43. 43.
    Tomb R. Allergic contact dermatitis from eosin. Contact Dermatitis 1991; 24:27–29PubMedCrossRefGoogle Scholar
  44. 44.
    Wuthrich B. Minimal forms of atopic eczema. In: Ruzicka T, Ring J, Przybilla B (Eds). Handbook of atopic eczema. Heidelberg: Springer, 1991; 46–53Google Scholar
  45. 45.
    Hannuksela M, Lahti A. Immediate reactions to fruits and vegetables. Contact Dermatitis 3:79–84Google Scholar
  46. 46.
    Lahti A. Immediate contact reactions. In: Rycroft RJG, Menne T, Frosch PJ, Benezra C (eds): Textbook of contact dermatitis. Heidelberg: Springer, 1992; 62–74Google Scholar
  47. 47.
    Bruynzeel-Koomen C. IgE on Langerhans cells: new insights into the pathogenesis of atopic dermatitis. Dermatologica 1986; 72:181–183CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1999

Authors and Affiliations

  • L. E. Millikan

There are no affiliations available

Personalised recommendations